The US Congress is working on changes to the Biosecure Act, a bill aimed at targeting Chinese companies involved in bioterrorism. However, these proposed updates have raised concerns about due process and fairness. Key changes include exemptions for specific Chinese companies that could allow them to avoid sanctions.
The legislative push faces time constraints as lawmakers work against a looming deadline. Proponents of the bill aim to balance demands from China hawks who want to hold specific companies accountable with those calling for more due process. The outcome remains uncertain, leaving the future of the Biosecure Act in doubt.
Source: https://www.biocentury.com/article/654396/biosecure-compromise-in-the-works-fate-uncertain-as-deadline-nears